Check Up: Creso Pharma gets really, really high; leads ASX health sector
News
Here’s our fortnightly wrap of all the news driving ASX health stocks.
It’s been a great month for the ASX healthcare sector with 90 stocks gaining ground and just 32 losing it. Another five companies treaded water.
Code | Company | Price | MktCap | Month return | Week return | %Yr |
---|---|---|---|---|---|---|
CPH | Creso Pharma Ltd | 0.415 | $ 161,778,328.00 | 1496 | 730 | 196 |
SCU | Stemcell United Ltd | 0.041 | $ 15,446,992.37 | 141 | 156 | 193 |
AVE | Avecho Biotech Ltd | 0.026 | $ 27,156,776.14 | 86 | 117 | 550 |
NTI | Neurotech Intl | 0.061 | $ 27,536,384.81 | 165 | 110 | 281 |
AMT | Allegra Orthopaedics | 0.37 | $ 38,127,609.10 | 147 | 100 | 68 |
AC8 | Auscann Grp Hlgs Ltd | 0.245 | $ 76,091,365.68 | 75 | 81 | 29 |
MXC | Mgc Pharmaceuticals | 0.0375 | $ 46,199,027.48 | 70 | 79 | 14 |
CP1 | Cannpal Animal | 0.205 | $ 18,625,000.00 | 95 | 52 | 58 |
TD1 | Tali Digital Limited | 0.054 | $ 40,462,481.77 | 86 | 50 | 2 |
JHL | Jayex Healthcare Ltd | 0.053 | $ 9,866,788.18 | 47 | 43 | 83 |
CAN | Cann Group Ltd | 0.725 | $ 183,590,057.04 | 127 | 42 | 58 |
EXL | Elixinol Global | 0.27 | $ 63,877,277.19 | 86 | 42 | -64 |
MMJ | MMJ Group Hlds Ltd | 0.175 | $ 37,942,407.53 | 67 | 40 | 13 |
RHY | Rhythm Biosciences | 0.845 | $ 161,196,648.80 | 238 | 39 | 566 |
RHT | Resonance Health | 0.215 | $ 68,955,459.62 | 34 | 34 | -2 |
ZLD | Zelira Therapeutics | 0.11 | $ 112,605,681.77 | 49 | 33 | 71 |
VBS | Vectus Biosystems | 1.35 | $ 40,835,458.26 | 40 | 27 | 129 |
PIQ | Proteomics Int Lab | 0.69 | $ 67,664,289.38 | 35 | 27 | 126 |
APH | AP Hemp Ltd | 0.415 | $ 21,031,926.00 | 113 | 22 | 144 |
THC | THC Global Grp Ltd | 0.29 | $ 52,644,799.96 | 38 | 21 | -26 |
IDT | IDT Australia Ltd | 0.22 | $ 47,664,932.80 | 33 | 19 | 63 |
BD1 | Bard1 Life Sciences | 0.78 | $ 61,060,595.58 | 4 | 18 | -17 |
IHL | Incannex Healthcare | 0.165 | $ 178,942,599.33 | 96 | 18 | 146 |
MX1 | Micro-X Limited | 0.365 | $ 129,363,031.08 | 46 | 16 | 86 |
PAA | Pharmaust Limited | 0.12 | $ 37,977,590.40 | 0 | 14 | 14 |
ICS | ICSGlobal Limited | 2.11 | $ 22,205,680.09 | 23 | 13 | 0 |
PNV | Polynovo Limited | 3.82 | $ 2,512,134,567.20 | 40 | 13 | 115 |
OIL | Optiscan Imaging | 0.135 | $ 80,558,590.50 | 36 | 13 | 255 |
DVL | Dorsavi Ltd | 0.036 | $ 10,153,680.10 | 16 | 13 | 45 |
LBT | LBT Innovations | 0.14 | $ 37,536,576.35 | 17 | 12 | -15 |
NEU | Neuren Pharmaceut. | 1.31 | $ 148,990,540.40 | 27 | 11 | -42 |
CGS | Cogstate Ltd | 1.07 | $ 182,048,014.17 | -18 | 11 | 234 |
1AD | Adalta Limited | 0.13 | $ 34,324,619.42 | 18 | 11 | 25 |
OSP | Osprey Med Inc | 0.022 | $ 35,713,633.16 | 10 | 10 | -42 |
MDC | Medlab Clinical Ltd | 0.275 | $ 72,715,674.46 | 41 | 10 | -20 |
NYR | Nyrada Inc. | 0.25 | $ 17,563,897.10 | 16 | 9 | 0 |
IVX | Invion Ltd | 0.013 | $ 66,444,507.54 | 18 | 8 | -7 |
NC6 | Nanollose Limited | 0.054 | $ 6,412,451.13 | -13 | 8 | 1 |
ONT | 1300 Smiles Limited | 7.08 | $ 167,642,958.72 | 10 | 8 | 12 |
PBP | Probiotec Limited | 2.34 | $ 177,225,921.90 | 34 | 7 | 26 |
RCE | Recce Pharmaceutical | 1.21 | $ 210,190,521.75 | 27 | 6 | 357 |
LSH | Lifespot Health Ltd | 0.086 | $ 10,727,619.63 | 30 | 5 | 153 |
PCK | Painchek Ltd | 0.084 | $ 94,651,603.12 | -6 | 5 | -58 |
GLH | Global Health Ltd | 0.44 | $ 17,260,311.20 | 16 | 5 | 203 |
CYC | Cyclopharm Limited | 2.6 | $ 208,713,583.00 | 29 | 4 | 139 |
ICR | Intelicare Holdings | 0.265 | $ 9,333,811.50 | 2 | 4 | 0 |
BNO | Bionomics Limited | 0.135 | $ 88,229,706.00 | 23 | 4 | 49 |
PSQ | Pacific Smiles Grp | 2.02 | $ 325,452,966.00 | 2 | 4 | 20 |
CYP | Cynata Therapeutics | 0.785 | $ 91,942,343.14 | -13 | 3 | -29 |
ATH | Alterity Therap Ltd | 0.032 | $ 67,021,349.27 | 19 | 3 | 39 |
HCT | Holista CollTech Ltd | 0.066 | $ 18,173,039.74 | -20 | 3 | -12 |
AGH | Althea Group | 0.53 | $ 128,360,334.57 | 31 | 3 | 51 |
S66 | Star Combo | 0.36 | $ 48,496,488.84 | 4 | 3 | -22 |
SUD | Suda Pharmaceuticals | 0.039 | $ 11,659,764.28 | 0 | 3 | -30 |
BWX | BWX Limited | 4.02 | $ 555,385,112.04 | 7 | 3 | -10 |
SOM | SomnoMed Limited | 2.21 | $ 186,208,458.75 | 17 | 2 | -10 |
KZA | Kazia Therapeutics | 1.42 | $ 170,955,287.72 | 73 | 2 | 128 |
SDI | SDI Limited | 0.81 | $ 96,281,079.30 | 3 | 1 | -6 |
RAC | Race Oncology Ltd | 2.09 | $ 270,415,226.25 | 95 | 1 | 1167 |
VLS | Vita Life Sciences.. | 0.89 | $ 48,133,524.68 | 0 | 0 | 37 |
SVA | Simavita Ltd | 0.016 | $ 18,461,854.56 | -11 | 0 | -27 |
RSH | Respiri Limited | 0.16 | $ 111,497,822.45 | -9 | 0 | 88 |
RGS | Regeneus Ltd | 0.12 | $ 31,529,860.01 | -4 | 0 | 26 |
PAL | Palla Pharma Ltd | 0.8 | $ 100,128,641.72 | 13 | 0 | -2 |
PAB | Patrys Limited | 0.02 | $ 29,661,301.89 | -4 | 0 | -8 |
OVN | Oventus Medical Ltd | 0.24 | $ 40,356,916.34 | 12 | 0 | -62 |
MVP | Medical Developments | 7.05 | $ 465,926,786.10 | 24 | 0 | -3 |
MDR | Medadvisor Limited | 0.385 | $ 134,295,374.29 | -2 | 0 | 18 |
LCT | Living Cell Tech. | 0.014 | $ 8,000,173.73 | 17 | 0 | -18 |
IBX | Imagion Biosys Ltd | 0.13 | $ 129,096,404.97 | 73 | 0 | 673 |
FFC | Farmaforce Ltd | 0.085 | $ 10,945,533.30 | 21 | 0 | -23 |
CAJ | Capitol Health | 0.28 | $ 281,902,434.00 | 6 | 0 | 19 |
BXN | Bioxyne Ltd | 0.012 | $ 7,681,744.78 | 9 | 0 | -20 |
BIT | Biotron Limited | 0.083 | $ 54,750,751.61 | 0 | 0 | 41 |
ATX | Amplia Therapeutics | 0.225 | $ 24,200,804.70 | 7 | 0 | 224 |
ALT | Analytica Limited | 0.003 | $ 12,318,643.16 | 50 | 0 | 0 |
AHK | Ark Mines Limited | 0.034 | $ 1,778,919.95 | 0 | 0 | 0 |
ACW | Actinogen Medical | 0.021 | $ 30,466,530.55 | -5 | 0 | -52 |
ACR | Acrux Limited | 0.175 | $ 28,687,058.51 | 6 | 0 | -8 |
1ST | 1St Group Ltd | 0.041 | $ 17,409,293.02 | 14 | 0 | -44 |
ZNO | Zoono Group Ltd | 1.39 | $ 224,149,408.59 | -9 | 0 | 479 |
NXS | Next Science Limited | 1.25 | $ 154,119,074.54 | 4 | 0 | -39 |
CDY | Cellmid Limited | 0.096 | $ 12,023,699.14 | -4 | -1 | -62 |
RAP | Resapp Health Ltd | 0.089 | $ 68,230,754.01 | 3 | -1 | -68 |
GSS | Genetic Signatures | 1.77 | $ 255,745,795.34 | -11 | -1 | 73 |
VHT | Volpara Health Tech | 1.36 | $ 346,384,251.78 | 5 | -1 | -24 |
AT1 | Atomo Diagnostics | 0.31 | $ 128,485,456.16 | -9 | -2 | 0 |
IMM | Immutep Ltd | 0.28 | $ 175,584,360.66 | -3 | -2 | 17 |
ONE | Oneview Healthcare | 0.052 | $ 11,558,501.93 | 36 | -2 | -49 |
DXB | Dimerix Ltd | 0.25 | $ 49,468,574.25 | -6 | -2 | 100 |
PGC | Paragon Care Limited | 0.24 | $ 82,781,896.54 | 23 | -2 | -46 |
IMC | Immuron Limited | 0.235 | $ 53,306,813.91 | 3 | -2 | 62 |
PXS | Pharmaxis Ltd | 0.089 | $ 35,716,981.32 | -10 | -2 | -66 |
JHC | Japara Healthcare Lt | 0.685 | $ 184,400,656.32 | 76 | -4 | -36 |
EYE | Nova EYE Medical Ltd | 0.34 | $ 48,824,386.92 | 3 | -3 | 8 |
MVF | Monash IVF Group Ltd | 0.72 | $ 280,537,084.80 | 15 | -3 | -27 |
AHC | Austco Healthcare | 0.092 | $ 26,145,383.49 | -2 | -3 | 37 |
UBI | Universal Biosensors | 0.45 | $ 84,299,138.25 | 34 | -3 | 109 |
OCC | Orthocell Limited | 0.41 | $ 76,686,587.16 | 21 | -4 | -19 |
BOT | Botanix Pharma Ltd | 0.135 | $ 131,314,235.94 | 48 | -4 | 45 |
ARX | Aroa Biosurgery | 1.22 | $ 361,590,314.75 | -6 | -4 | 0 |
4DX | 4Dmedical Limited | 2.25 | $ 387,981,084.71 | -2 | -4 | 0 |
TLX | Telix Pharmaceutical | 3.56 | $ 1,034,407,582.50 | 51 | -4 | 112 |
PTX | Prescient Ltd | 0.065 | $ 42,276,498.66 | 8 | -4 | -35 |
OSX | Osteopore Limited | 0.54 | $ 42,140,412.00 | -4 | -4 | -34 |
ALC | Alcidion Group Ltd | 0.2 | $ 208,045,750.92 | 60 | -5 | -2 |
CMP | Compumedics Limited | 0.495 | $ 87,695,659.26 | 13 | -5 | -42 |
IMU | Imugene Limited | 0.12 | $ 552,414,225.48 | 94 | -6 | 231 |
GTG | Genetic Technologies | 0.008 | $ 66,093,813.94 | 7 | -6 | 78 |
ADO | Anteotech Ltd | 0.094 | $ 166,993,529.45 | -4 | -6 | 433 |
CTE | Cryosite Limited | 0.31 | $ 14,526,464.53 | 27 | -6 | 474 |
PYC | PYC Therapeutics | 0.145 | $ 475,638,915.45 | -15 | -6 | 161 |
ADR | Adherium Ltd | 0.027 | $ 18,320,419.62 | 4 | -7 | -29 |
PAR | Paradigm Bio. | 2.77 | $ 641,284,916.32 | -8 | -7 | -22 |
ANP | Antisense Therapeut. | 0.097 | $ 60,268,757.96 | -3 | -8 | 1 |
MEM | Memphasys Ltd | 0.12 | $ 90,572,865.60 | 9 | -8 | 135 |
M7T | Mach7 Tech Limited | 1.22 | $ 300,404,544.00 | 30 | -8 | 82 |
BPH | BPH Energy Ltd | 0.033 | $ 18,656,197.77 | -25 | -8 | 280 |
OPT | Opthea Limited | 2.1 | $ 709,094,754.90 | -5 | -9 | -29 |
VTI | Vision Tech, Inc | 0.029 | $ 28,818,041.21 | -3 | -9 | -51 |
CDX | Cardiex Limited | 0.05 | $ 41,047,369.87 | 9 | -11 | 79 |
IPD | Impedimed Limited | 0.14 | $ 150,723,449.80 | 68 | -11 | -11 |
RNO | Rhinomed Ltd | 0.15 | $ 38,071,369.80 | -14 | -14 | -25 |
NOX | Noxopharm Limited | 0.54 | $ 118,713,340.61 | 8 | -16 | 85 |
MEB | Medibio Limited | 0.01 | $ 13,476,625.69 | 11 | -17 | -14 |
NSB | Neuroscientific | 0.255 | $ 22,591,604.13 | -15 | -18 | 21 |
OSL | Oncosil Medical | 0.135 | $ 113,327,589.78 | -18 | -18 | -19 |
CBL | Control Bionics | 0.965 | $52,038,777 | 61 | ||
DOC | Doctor Care Anywhere | 0.835 | $136,797,547.09 | 4 |
The biggest gainer – by far – has been cannabis company Creso Pharma (ASX:CPH), whose shares were up nearly 16-fold for the month when this list was compiled yesterday afternoon.
After trading for 3c for most of October and November, CPH shares have been on an absolute tear in the last two weeks as talk of the downscheduling of cannibidoil grew louder, reaching as high as 46c around midday Wednesday.
They eased later in the afternoon, closing at 30c – making the stock “just” a ten-bagger in the past fortnight.
Never seen anything like it $CPH
Fence sitting and admiring on this one. Has there been such a vertical line pic.twitter.com/WPePiHDZUz— SC Azz (@sc_junkiie) December 8, 2020
$CPH, u just buy and close your eyes 😬😂
— Harvest (@_MaggiesFarm) December 7, 2020
Speculation about possible marijuana decriminalisation in the United States and momentum for Creso’s Canadian subsidiary Mernova Medicinal seem to be driving CPH shares.
(Fair warning, though: it’s very unlikely the United States will move on marijuana in the current session of Congress, given that Republicans still control the Senate. The best prospects for federal cannabis reform in the near term is if Democrats win two runoff Senate races January 5 in Georgia).
The second-biggest gainer for the period from November 9 to December 9 was Rhythm Biosciences (ASX:RHY), whose shares were up 238 per cent to 84.5c as the company works to bring its rapid blood test for bowel cancer to market.
Neurotech International (ASX:NTI) was the third-biggest gainer, up 165 per cent to 6.1c as the neurotechnology company made progress on researching its unique strains of hemp.
On the flip side, BPH Energy (ASX:BPH) shares were down 25 per cent to 3.3c – although still up 280 per cent for the year.
At Stockhead, we tell it like it is. Although Creso Pharma and Neurotech International are Stockhead advertisers, they didn’t sponsor this story.